News

Sorted by: Date | Title

Dana-Farber/Boston Children's named a top pediatric cancer program

June 16, 2020
U.S. News & World Report has named Dana-Farber/Boston Children's Cancer and Blood Disorders Center the top pediatric cancer program in New England and #2 in the nation in its 2020-21 Best Children's Hospitals report.

Population-based registry data identifies novel cancer patterns in families of childhood cancer patients

May 20, 2020
A collaboration between the Finnish Cancer Registry and Dana-Farber/Boston Children’s Cancer and Blood Disorders Center explored the utility of population-based registry data to screen childhood cancer patients for history of familial cancer. The study opened a new method for identifying high risk families that may reveal possible novel cancer predisposition genes.

2020 Harrington Prize awarded to Dr. Stuart H. Orkin

April 16, 2020
The Harrington Discovery Institute and The American Society for Clinical Investigation honor Dr. Orkin for his contributions to red blood cell biology.

Massive study reveals how 'hypermutated' malignant brain tumors with many mutations escape chemotherapy and immunotherapy

April 15, 2020
The report’s authors include investigators from Dana-Farber, Brigham and Women’s, Dana-Farber/Boston Children’s Cancer and Blood Disorders Center, the Broad Institute of MIT and Harvard, and Pitié-Salpêtrière hospitals in Paris, France, among others.

Bauer earns Outstanding New Investigator Award from ASGCT

April 10, 2020
Daniel Bauer, MD, PhD, is a physician-scientist whose research focuses on functional genomics to dissect determinants of blood cell development and disease and develop innovative therapies.

Pioneering a ‘Staple’ Approach for Treating COVID-19

April 09, 2020
Strategies to bar the coronavirus (COVID-19) from entering cells — thereby preventing infection and averting transmission of the virus — are among the most promising treatment approaches to COVID-19.

Dana-Farber/Boston Children’s receives $200,000 grant from Hyundai Hope On Wheels to support COVID-19 testing

April 08, 2020
Dana-Farber/Boston Children’s physicians have implemented crucial testing protocols during this unusual time, with a focus that children with cancer need life-saving treatments even in the setting of a viral pandemic.

Shimamura named recipient of the 2020 Frank A. Oski Memorial Lectureship from ASPHO

March 05, 2020
Past recipients with ties to Dana-Farber/Boston Children’s include Joanne Wolfe, MD, MPH (2016); Scott A. Armstrong, MD, PhD (2014); David Williams, MD (2006); and Stuart Orkin, MD (2003).

Count Me In launches Osteosarcoma Project

February 28, 2020
The patient-partnered initiative will enable anyone in the USA and Canada affected by osteosarcoma to participate.

The Osteosarcoma Institute to fund clinical trial in recurrent osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

February 27, 2020
The clinical trial will investigate the effectiveness of a combination of two oral drugs targeting the DNA damage response pathway.
Showing 1-10 of 247 items